Demandware Inc (NYSE:DWRE): After conducting checks, Oppenheimer believes that the data indicates that Demandware is well-positioned to gain market share. The firm reiterates an Outperform rating on the stock.
Moog Inc (NYSE:MOG.A): Cowen said shares of Moog look oversold following its recent 20% decline. The firm cut its 2013 estimates to account for headwinds in Asia and Europe but believes solid Q2 results and a positive outlook could be a catalyst for the shares. Shares are Outperform rated.
Garmin Ltd. (NASDAQ:GRMN): Oppenheimer believes that Garmin (NASDAQ:GRMN) is executing exceptionally well. However, the firm believes that an upcoming update by Apple (NASDAQ:AAPL) could add turn-by-turn navigation to iOS, causing investors to once again worry about the outlook for personal navigation device makers. The firm maintains a Perform rating on Garmin.
Keryx Biopharmaceuticals Inc. (NASDAQ:KERX): Oppenheimer believes that investors are undervaluing Keryx’s Zerenex due to concerns about pricing pressures from a generic drug, but the firm continues to believe that Zerenex will sell for $2,500/ptn per year. The firm finds Keryx’s risk/reward ratio over the next 12-18 months.attractive and it maintains an Outperform rating on the shares.
Akamai Technologies Inc. (NASDAQ:AKAM): Cowen said their bullish stance for Akamai was reaffirmed following last week’s investor meetings. The firm said demand for CDN services remains strong, top-line growth is still strong, and recent headline risks are not likely to have any impact. Shares are Outperform rated.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.